BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34670117)

  • 21. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
    Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
    Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.
    Liang Y; Zhao Q; Fan L; Zhang Z; Tan B; Liu Y; Li Y
    Biomed Pharmacother; 2015 Oct; 75():137-41. PubMed ID: 26320367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells.
    Zhang J; Sun Z; Han Y; Yao R; Yue L; Xu Y; Zhang J
    Oncol Lett; 2017 May; 13(5):3817-3822. PubMed ID: 28529595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis for RASSF10/NPM/RNF2 feedback cascade-mediated regulation of gastric cancer cell proliferation.
    Lakshmi Ch NP; Sivagnanam A; Raja S; Mahalingam S
    J Biol Chem; 2021 Aug; 297(2):100935. PubMed ID: 34224728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.
    Klusmann I; Wohlberedt K; Magerhans A; Teloni F; Korbel JO; Altmeyer M; Dobbelstein M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11311-E11320. PubMed ID: 30413623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of FoxO6 on proliferation and invasion of colorectal cancer cells].
    Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):369-375. PubMed ID: 32482025
    [No Abstract]   [Full Text] [Related]  

  • 28. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
    Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
    Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
    He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
    Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability.
    Wang TH; Chang JL; Ho JY; Wu HC; Chen TC
    FEBS J; 2012 Jan; 279(2):251-63. PubMed ID: 22074469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.
    Mathur PS; Gierut JJ; Guzman G; Xie H; Xicola RM; Llor X; Chastkofsky MI; Perekatt AO; Tyner AL
    Mol Cancer Res; 2016 Jun; 14(6):563-73. PubMed ID: 26983689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
    Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Li XD; Chen SL; Dong P; Chen JW; Wang FW; Guo SJ; Jiang LJ; Zhou FJ; Xie D; Liu ZW
    Sci Rep; 2016 Feb; 6():20894. PubMed ID: 26869491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarein inhibits the development of colon cancer via CDC4‑mediated RAGE ubiquitination.
    Li Y; Wang J; Zhong S; Li J; Du W
    Int J Mol Med; 2020 Apr; 45(4):1059-1072. PubMed ID: 32124957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
    Xu Y; Feng Y; Sun Z; Li Q
    Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
    Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
    Shen J; Li P; Shao X; Yang Y; Liu X; Feng M; Yu Q; Hu R; Wang Z
    Cancer Res; 2018 Jan; 78(2):359-371. PubMed ID: 29187402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
    Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
    Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.